Page 1 of Clinical Trials for Inotek Pharmaceuticals Corporation [SPONSOR-COLLABORATORS], 4 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Study of INO-1001, an Intravenous PARP (Poly [ADP Ribose] Polymerase) Inhibitor in Acute Heart Attack Patients Undergoing Primary Percutaneous Coronary Intervention
Last Updated: November 27, 2006
Condition(s): Acute Myocardial Infarction
2
Active, not recruiting
A Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves Heart-Lung Bypass
Last Updated: December 11, 2006
Condition(s): Heart Diseases; Postoperative Complications
3
Completed
Phase I Dose-Escalation Study to Evaluate Tolerability, Safety & PK of INO-8875 in Healthy Older-Adult Volunteers
Last Updated: April 27, 2012
Condition(s): Health
4
Recruiting
A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Last Updated: August 30, 2011
Condition(s): Glaucoma; Ocular Hypertension

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Inotek+Pharmaceuticals+Corporation

Page 1 of Clinical Trials for Inotek Pharmaceuticals Corporation [SPONSOR-COLLABORATORS], 4 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About